Published in Hum Gene Ther on July 01, 2010
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther (2011) 2.06
Autophagy as a new therapeutic target in Duchenne muscular dystrophy. Cell Death Dis (2012) 1.89
Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy. Mol Ther (2011) 1.04
Gene therapy for muscular dystrophy: moving the field forward. Pediatr Neurol (2014) 0.91
Dose response in rodents and nonhuman primates after hydrodynamic limb vein delivery of naked plasmid DNA. Hum Gene Ther (2011) 0.83
Hydrostatic isolated limb perfusion with adeno-associated virus vectors enhances correction of skeletal muscle in Pompe disease. Gene Ther (2010) 0.81
High-Pressure Transvenous Perfusion of the Upper Extremity in Human Muscular Dystrophy: A Safety Study with 0.9% Saline. Hum Gene Ther (2015) 0.78
Condensation of plasmid DNA enhances mitochondrial association in skeletal muscle following hydrodynamic limb vein injection. Pharmaceuticals (Basel) (2014) 0.75
A targeted controlled force injection of genetic material in vivo. Mol Ther Methods Clin Dev (2016) 0.75
DNA-Mediated Gene Therapy in a Mouse Model of Limb Girdle Muscular Dystrophy 2B. Mol Ther Methods Clin Dev (2017) 0.75
Direct gene transfer into mouse muscle in vivo. Science (1990) 10.39
Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med (1997) 4.87
Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci U S A (1996) 4.76
Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature (1993) 2.73
A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. Mol Ther (2004) 2.16
Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum Gene Ther (1997) 2.09
Gene therapy progress and prospects: hydrodynamic gene delivery. Gene Ther (2006) 1.86
A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy. J Transl Med (2007) 1.86
Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum Gene Ther (1993) 1.66
Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle. Mol Ther (2008) 1.63
Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther (1998) 1.52
Computer-assisted hydrodynamic gene delivery. Mol Ther (2008) 1.40
Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys. J Comp Neurol (1998) 1.39
Uniform scale-independent gene transfer to striated muscle after transvenular extravasation of vector. Circulation (2005) 1.30
Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth. Hum Gene Ther (2009) 1.21
The efficient expression of intravascularly delivered DNA in rat muscle. Gene Ther (1998) 1.20
Evaluation of vascular delivery methodologies to enhance rAAV6-mediated gene transfer to canine striated musculature. Mol Ther (2009) 1.13
Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle. J Cell Sci (1992) 1.09
Evaluation of animal models of Parkinson's disease for neuroprotective strategies. J Neurosci Methods (2004) 1.08
Efficient expression of naked dna delivered intraarterially to limb muscles of nonhuman primates. Hum Gene Ther (2001) 1.07
Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route. Hum Gene Ther (2000) 1.06
Biomechanics of skeletal muscle capillaries: hemodynamic resistance, endothelial distensibility, and pseudopod formation. Ann Biomed Eng (1995) 1.04
Comparison of ketamine versus combination of ketamine and medetomidine in injectable anesthetic protocols: chemical immobilization in macaques and tissue reaction in rats. Contemp Top Lab Anim Sci (2003) 0.97
Optimization of regional intraarterial naked DNA-mediated transgene delivery to skeletal muscles in a large animal model. Mol Ther (2005) 0.93
Rapid intravascular injection into limb skeletal muscle: a damage assessment study. Mol Ther (2005) 0.91
Muscular gene transfer using nonviral vectors. Curr Gene Ther (2008) 0.91
Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA. Gene Ther (2004) 0.90
Progress toward a nonviral gene therapy protocol for the treatment of anemia. Hum Gene Ther (2007) 0.88
Magnetic resonance imaging-monitored plasmid DNA delivery in primate limb muscle. Hum Gene Ther (2007) 0.88
Wallerian degeneration in human nerves: serial electrophysiological studies. Muscle Nerve (1992) 0.88
Opening the floodgates: clinically applicable hydrodynamic delivery of plasmid DNA to skeletal muscle. Mol Ther (2004) 0.83
Limb exsanguination for Bier's block. Anaesthesia (1979) 0.78
Capillary density in skeletal muscle of Wistar rats as a function of muscle weight and body weight. Microvasc Res (1996) 0.77
The pentacovalent phosphorus intermediate of a phosphoryl transfer reaction. Science (2003) 3.41
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci U S A (2007) 3.30
Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet (2002) 3.08
Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano (2009) 2.39
Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci U S A (2010) 2.33
A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. Mol Ther (2004) 2.16
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther (2011) 2.06
Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection. Nat Med (2012) 1.74
An invasive podosome-like structure promotes fusion pore formation during myoblast fusion. J Cell Biol (2010) 1.59
Medium chain acyl-coenzyme A dehydrogenase deficiency in a neonate. N Engl J Med (2007) 1.55
Contributions of non-human primates to neuroscience research. Lancet (2008) 1.54
Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease. Neurosurgery (2002) 1.54
Collective cell migration requires vesicular trafficking for chemoattractant delivery at the trailing edge. J Cell Biol (2008) 1.48
Caught in the act: the structure of phosphorylated beta-phosphoglucomutase from Lactococcus lactis. Biochemistry (2002) 1.43
Nanoscale 3D cellular imaging by axial scanning transmission electron tomography. Nat Methods (2009) 1.32
Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids. Am J Clin Nutr (2009) 1.32
Initial loss but later excess of GABAergic synapses with dentate granule cells in a rat model of temporal lobe epilepsy. J Comp Neurol (2010) 1.30
Specification of midbrain dopamine neurons from primate pluripotent stem cells. Stem Cells (2012) 1.28
Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study. J Pediatr (2009) 1.27
Mechanism of plasmid delivery by hydrodynamic tail vein injection. I. Hepatocyte uptake of various molecules. J Gene Med (2006) 1.25
Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett (2011) 1.24
Golgi fragmentation is associated with ceramide-induced cellular effects. Mol Biol Cell (2005) 1.21
Analysis of the substrate specificity loop of the HAD superfamily cap domain. Biochemistry (2004) 1.20
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys. J Neuroinflammation (2011) 1.19
Endosomolysis by masking of a membrane-active agent (EMMA) for cytoplasmic release of macromolecules. Bioconjug Chem (2003) 1.18
Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas. Proc Natl Acad Sci U S A (2006) 1.18
Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Mol Ther (2013) 1.16
Competition between Blown fuse and WASP for WIP binding regulates the dynamics of WASP-dependent actin polymerization in vivo. Dev Cell (2011) 1.14
Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery. Biomaterials (2012) 1.13
Delivery of siRNA and siRNA expression constructs to adult mammals by hydrodynamic intravascular injection. Methods Enzymol (2005) 1.10
Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes. Front Biosci (2003) 1.09
Chronic ischemic stroke model in cynomolgus monkeys: behavioral, neuroimaging and anatomical study. Neurol Res (2003) 1.09
Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes. Biomaterials (2012) 1.09
Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice. Nucleic Acids Res (2006) 1.08
L-carnitine administration reduces number of episodes in cyclic vomiting syndrome. Clin Pediatr (Phila) (2002) 1.06
Chemical confirmation of a pentavalent phosphorane in complex with beta-phosphoglucomutase. J Am Chem Soc (2005) 1.05
Intraarterial delivery of naked plasmid DNA expressing full-length mouse dystrophin in the mdx mouse model of duchenne muscular dystrophy. Hum Gene Ther (2004) 1.05
Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong population by newborn screening using tandem mass spectrometry. Pediatrics (2003) 1.05
Correction of murine PKU following AAV-mediated intramuscular expression of a complete phenylalanine hydroxylating system. Mol Ther (2008) 1.05
The effect of cell division on the cellular dynamics of microinjected DNA and dextran. Mol Ther (2002) 1.04
Mechanism of plasmid delivery by hydrodynamic tail vein injection. II. Morphological studies. J Gene Med (2006) 1.04
Analysis of the structural determinants underlying discrimination between substrate and solvent in beta-phosphoglucomutase catalysis. Biochemistry (2009) 1.04
Systemic siRNA delivery via hydrodynamic intravascular injection. Adv Drug Deliv Rev (2007) 1.03
Effect of tissue-specific promoters and microRNA recognition elements on stability of transgene expression after hydrodynamic naked plasmid DNA delivery. Hum Gene Ther (2009) 1.02
Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy. Hum Gene Ther (2004) 1.01
Condensation of nonstochiometric DNA/polycation complexes by divalent cations. Biopolymers (2006) 1.00
Solution structure of Alg13: the sugar donor subunit of a yeast N-acetylglucosamine transferase. Structure (2008) 1.00
Alkaline ceramidase 2 regulates beta1 integrin maturation and cell adhesion. FASEB J (2008) 1.00
Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5. Oncotarget (2013) 0.97
Adjuvant therapy for hepatocellular carcinoma: current situation and prospect. Drug Discov Ther (2013) 0.97
The deceptive nature of UVA tanning versus the modest protective effects of UVB tanning on human skin. Pigment Cell Melanoma Res (2010) 0.97
Pathways of infusate loss during convection-enhanced delivery into the putamen nucleus. Stereotact Funct Neurosurg (2013) 0.96
Group I PAKs function downstream of Rac to promote podosome invasion during myoblast fusion in vivo. J Cell Biol (2012) 0.96
Manipulating the power of an additional phase: a flower-like Au-Fe3O4 optical nanosensor for imaging protease expressions in vivo. ACS Nano (2011) 0.95
In vitro evidence for the dual function of Alg2 and Alg11: essential mannosyltransferases in N-linked glycoprotein biosynthesis. Biochemistry (2006) 0.95
Use of Evans blue dye to compare limb muscles in exercised young and old mdx mice. Muscle Nerve (2010) 0.94
Sustained liver-specific transgene expression from the albumin promoter in mice following hydrodynamic plasmid DNA delivery. J Gene Med (2008) 0.94
Mood, memory and movement: an age-related neurodegenerative complex? Curr Aging Sci (2008) 0.93
The role of molecular testing and enzyme analysis in the management of hypomorphic citrullinemia. Am J Med Genet A (2008) 0.92
Dual-axis electron tomography of biological specimens: Extending the limits of specimen thickness with bright-field STEM imaging. J Struct Biol (2010) 0.92
Expression of GAD65 and GAD67 immunoreactivity in MPTP-treated monkeys with or without L-DOPA administration. Neurobiol Dis (2005) 0.92
Diversification of function in the haloacid dehalogenase enzyme superfamily: The role of the cap domain in hydrolytic phosphoruscarbon bond cleavage. Bioorg Chem (2006) 0.91
Rapid intravascular injection into limb skeletal muscle: a damage assessment study. Mol Ther (2005) 0.91
Strategies for improving animal models for regenerative medicine. Cell Stem Cell (2013) 0.90
Membrane activity and transfection ability of amphipathic polycations as a function of alkyl group size. Bioconjug Chem (2005) 0.90
Survival and early differentiation of human neural stem cells transplanted in a nonhuman primate model of stroke. J Neurosurg (2006) 0.89
Surgical procedures for intravascular delivery of plasmid DNA to organs. Methods Enzymol (2002) 0.89
Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession. Neurobiol Aging (2012) 0.89
The genotype-dependent influence of functionalized multiwalled carbon nanotubes on fetal development. Biomaterials (2014) 0.89
Caveolin-1 regulates proliferation and osteogenic differentiation of human mesenchymal stem cells. J Cell Biochem (2012) 0.88
Progress toward a nonviral gene therapy protocol for the treatment of anemia. Hum Gene Ther (2007) 0.88
Magnetic resonance imaging-monitored plasmid DNA delivery in primate limb muscle. Hum Gene Ther (2007) 0.88
Elevated expression of TMEM205, a hypothetical membrane protein, is associated with cisplatin resistance. J Cell Physiol (2010) 0.88
Genetic immunization for antibody generation in research animals by intravenous delivery of plasmid DNA. Biotechniques (2006) 0.88
Increased retinoic acid levels through ablation of Cyp26b1 determine the processes of embryonic skin barrier formation and peridermal development. J Cell Sci (2012) 0.87
Delivery of small interfering RNA to mammalian cells in culture by using cationic lipid/polymer-based transfection reagents. Methods Enzymol (2005) 0.87
Bone marrow-derived keratinocytes are not detected in normal skin and only rarely detected in wounded skin in two different murine models. Exp Hematol (2006) 0.87
Lentviral-mediated RNAi to inhibit target gene expression of the porcine integrin αv subunit, the FMDV receptor, and against FMDV infection in PK-15 cells. Virol J (2011) 0.86
Blood vessels and parkinsonism. Front Biosci (2004) 0.86
Influence of melanosome dynamics on melanoma drug sensitivity. J Natl Cancer Inst (2009) 0.86
2-methylbutyryl-CoA dehydrogenase deficiency in Hmong infants identified by expanded newborn screen. WMJ (2007) 0.85
Nonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeys. PLoS One (2012) 0.85